FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a EP2 agonist which exhibits the EP3 agonist action, and induce a neurotising and/or protective effect and thereby is effective as a therapeutic agent for a peripheral nerve disease, such as lower and upper motor neuron disorder, nerve root disease, plexopathy, brachial plexus compression syndrome, peripheral neuropathy, neurofibromatosis and nervomuscular conduction disease.
EFFECT: EP2 agonist which exhibits the EP3 agonist action; it is a safe and effective neurotisation and/or protection agent which has an insignificant impact on the cardiovascular system.
13 cl, 36 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PROSTAGLANDIN DERIVATIVE | 2017 |
|
RU2748837C2 |
| COMPOUND, POSSESSING DETRUSOR-CONTRACTING AND URETHRAL SPHINCTER-RELAXING ACTIVITY | 2010 |
|
RU2531350C2 |
| DERIVATIVES OF TRIAZOLE OF AMIDE TYPE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR PROPHYLAXIS OR TREATMENT | 2001 |
|
RU2232761C2 |
| TRIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, USING TRIAZOLE COMPOUNDS AND METHOD FOR TREATMENT OF FUNGAL INFECTION | 2002 |
|
RU2276670C2 |
| AMINE SALT AND CRYSTALS THEREOF | 2013 |
|
RU2658823C2 |
| METHOD OF TREATMENT OF SCHIZOPHRENIA | 2012 |
|
RU2648474C2 |
| AGENTS CAUSING APOPTOSIS AND INTENDED FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2012 |
|
RU2594282C2 |
| 8-AZAPROSTAGLANDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND AGENT FOR PROPHYLAXIS OF DISEASES | 2003 |
|
RU2306309C2 |
| ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
| DERIVATIVES OF 2-PIPERIDONE AS PROSTAGLANDIN AGONISTS | 2004 |
|
RU2311409C2 |
